Prostate Cancer News and Research

Latest Prostate Cancer News and Research

DoD recommends funding for Synta's STA-9584 for prostate cancer study

DoD recommends funding for Synta's STA-9584 for prostate cancer study

Mass. regulators and nursing homes fight inappropriate medicating; officials deal with Hawaii doctor shortage

Mass. regulators and nursing homes fight inappropriate medicating; officials deal with Hawaii doctor shortage

Medicare committee recommends expensive drug for some prostate-cancer patients

Medicare committee recommends expensive drug for some prostate-cancer patients

Expert panel to endorse newly approved therapeutic vaccine for advanced prostate cancer

Expert panel to endorse newly approved therapeutic vaccine for advanced prostate cancer

Women prefer diet advice from women: Study

Women prefer diet advice from women: Study

Multidisciplinary clinic approach can improve survival in patients with aggressive prostate cancer

Multidisciplinary clinic approach can improve survival in patients with aggressive prostate cancer

New anti-cancer drug targeting vitamin D receptor reduces PSA level in HRPC

New anti-cancer drug targeting vitamin D receptor reduces PSA level in HRPC

MK-4827 drug candidate shows promising anti-tumour activity in first human trial

MK-4827 drug candidate shows promising anti-tumour activity in first human trial

Exelixis reports interim data of XL184 for metastatic castration-resistant prostate cancer

Exelixis reports interim data of XL184 for metastatic castration-resistant prostate cancer

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Mayo Clinic to establish pencil beam proton scanning facilities in Minnesota, Arizona and Florida

Mayo Clinic to establish pencil beam proton scanning facilities in Minnesota, Arizona and Florida

Predictive Biosciences, Epigenomics extend GSTP1 licensing agreement for prostate cancer

Predictive Biosciences, Epigenomics extend GSTP1 licensing agreement for prostate cancer

Enzon presents data on three investigational mRNA antagonists at EORTC-NCI-AACR Symposium

Enzon presents data on three investigational mRNA antagonists at EORTC-NCI-AACR Symposium

Medicare roundup: Payment cuts irk healthcare industry; officials mull new prostate-cancer treatment

Medicare roundup: Payment cuts irk healthcare industry; officials mull new prostate-cancer treatment

Progenics initiates ONO-3849 phase 2 clinical trial for OIC in Japan

Progenics initiates ONO-3849 phase 2 clinical trial for OIC in Japan

Risk reduction of 20 ailments with regular exercise: Review

Risk reduction of 20 ailments with regular exercise: Review

HUPTI's first group of patients complete prostate cancer treatment

HUPTI's first group of patients complete prostate cancer treatment

Men treated with hormone-based therapy for prostate cancer face higher risk of colorectal cancer: Study

Men treated with hormone-based therapy for prostate cancer face higher risk of colorectal cancer: Study

Protox decreases third quarter net and comprehensive loss to $1.6 million

Protox decreases third quarter net and comprehensive loss to $1.6 million

GTx presents preclinical studies of GTx-758 and GTx-230 for treatment of cancer

GTx presents preclinical studies of GTx-758 and GTx-230 for treatment of cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.